T 2491/16 (Bilayer tablet / BOEHRINGER INGELHEIM) of 07.03.2019
- European Case Law Identifier
- ECLI:EP:BA:2019:T249116.20190307
- Date of decision
- 7 March 2019
- Case number
- T 2491/16
- Petition for review of
- -
- Application number
- 05810652.7
- IPC class
- A61K 31/4184A61P 9/04A61P 25/28A61P 9/10A61K 9/20A61P 3/10A61P 9/00A61K 31/4422A61P 9/12A61P 9/08
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- BILAYER TABLET COMPRISING TELMISARTAN AND AMLODIPINE
- Applicant name
- Boehringer Ingelheim International GmbH
Boehringer Ingelheim Pharma GmbH & Co. KG - Opponent name
- ZAKLADY FARMACEUTYCZNE POLPHARMA S.A.
Oser, Andreas
KRKA, tovarna zdravil, d.d., Novo mesto - Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 100(b)European Patent Convention Art 56Rules of procedure of the Boards of Appeal Art 13(1)
- Keywords
- Sufficiency of disclosure - main request, auxiliary request 1 (no)
Sufficiency of disclosure - auxiliary request 2 (yes)
Inventive step - auxiliary request 2 (yes)
Late-filed documents
Late-filed document - admitted (partially) - Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the opposition division with the order to maintain the patent on the basis of the set of claims of auxiliary request 2 and a description to be adapted.